<DOC>
	<DOCNO>NCT02907736</DOCNO>
	<brief_summary>Acute Ischemic stroke ( AIS ) remain leading cause adult disability , cognitive impairment mortality worldwide despite development revascularization therapy ( intravenous Tissue Plasminogen Activator ( t-PA ) endovascular therapy ) . Thrombosis resistance IV t-PA therapy frequent especially case AIS proximal occlusion . In recent year , neutrophil extracellular trap ( NETs ) identify major trigger structural factor various form thrombosis . NETs extracellular web primarily compose DNA neutrophil . A recent study show NETs burden coronary thrombus positively correlate infarct size negatively correlate electrocardiogram ( ST-segment ) resolution . This late study reveal vitro addition DNase I accelerate t-PA-induced thrombolysis coronary thrombus . NETs could , consequence , promise target improve thrombolysis AIS . The aim study assess impact NETs composition thrombus retrieve endovascular therapy AIS patient IV t-PA induced thrombolysis , clinical outcome AIS etiology .</brief_summary>
	<brief_title>Impact Neutrophil Extracellular Traps Tissue Plasminogen Activator Induced Thrombolysis Acute Ischemic Stroke Patients</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>age &gt; 18 year old AIS secondary large vessel occlusion admit endovascular therapy . Pregnant breast feed patient patient legal protection Patient opposition participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>